Research output per year
Research output per year
Fingerprint
Dive into the research topics where Christopher Plaisier is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
KAT5 regulates neurodevelopmental states associated with G0-like populations in glioblastoma
Mihalas, A. B., Arora, S., O’Connor, S. A., Feldman, H. M., Cucinotta, C. E., Mitchell, K., Bassett, J., Kim, D., Jin, K., Hoellerbauer, P., Delegard, J., Ling, M., Jenkins, W., Kufeld, M., Corrin, P., Carter, L., Tsukiyama, T., Aronow, B., Plaisier, C. L. & Patel, A. P. & 1 others, , Dec 2025, In: Nature communications. 16, 1, 4327.Research output: Contribution to journal › Article › peer-review
-
microRNA-497-5p-based screening identifies a novel synthetic lethal-type interaction via PKMYT1 and WEE1 in pleural mesothelioma
Pruett, N., Wilferd, S., Singh, A., Choi, A. Y., Dixit, S., Singh, V., Nguyen, C., Lin, O., Schrump, D. S., Plaisier, C. L. & Hoang, C. D., Sep 9 2025, In: Molecular Therapy Nucleic Acids. 36, 3, 102610.Research output: Contribution to journal › Article › peer-review
-
Biomimetic nanodrug targets inflammation and suppresses YAP/TAZ to ameliorate atherosclerosis
Huang, H. C., Wang, T. Y., Rousseau, J., Orlando, M., Mungaray, M., Michaud, C., Plaisier, C., Chen, Z. B. & Wang, K. C., Apr 2024, In: Biomaterials. 306, 122505.Research output: Contribution to journal › Article › peer-review
12 Scopus citations -
Induction of Aryl Hydrocarbon Receptor-Mediated Cancer Cell-Selective Apoptosis in Triple-Negative Breast Cancer Cells by a High-Affinity Benzimidazoisoquinoline
Elson, D. J., Nguyen, B. D., Bernales, S., Chakravarty, S., Jang, H. S., Korjeff, N. A., Zhang, Y., Wilferd, S. F., Castro, D. J., Plaisier, C. L., Finlay, D., Oshima, R. G. & Kolluri, S. K., Jul 14 2023, In: ACS Pharmacology and Translational Science. 6, 7, p. 1028-1042 15 p.Research output: Contribution to journal › Article › peer-review
9 Scopus citations -
Integrated molecular and multiparametric MRI mapping of high-grade glioma identifies regional biologic signatures
Hu, L. S., D’Angelo, F., Weiskittel, T. M., Caruso, F. P., Fortin Ensign, S. P., Blomquist, M. R., Flick, M. J., Wang, L., Sereduk, C. P., Meng-Lin, K., De Leon, G., Nespodzany, A., Urcuyo, J. C., Gonzales, A. C., Curtin, L., Lewis, E. M., Singleton, K. W., Dondlinger, T., Anil, A. & Semmineh, N. B. & 40 others, , Dec 2023, In: Nature communications. 14, 1, 6066.Research output: Contribution to journal › Article › peer-review
Open Access18 Scopus citations
-
Engineering a human neuroimmune specific viral vector from Zika virus
Andrews, M. (CoI), Plaisier, C. (CoI) & Bartelle, B. (PI)
HHS: National Institutes of Health (NIH)
7/7/23 → 4/30/26
Project: Research project
-
Defining cellular states of quiescence in human brain tumors
Plaisier, C. (PI)
HHS: National Institutes of Health (NIH)
4/1/22 → 11/30/25
Project: Research project
-
Exploiting sex-dependent brain injury response for nanoparticle therapeutics - Resubmission - 1
Bimonte-Nelson, H. (CoI), Newbern, J. (CoI), Plaisier, C. (CoI) & Stabenfeldt, S. (PI)
HHS: National Institutes of Health (NIH)
1/1/21 → 11/30/25
Project: Research project
-
Discovery and delivery platform making small RNAs a viable therapeutic option for mesothelioma
Plaisier, C. (PI)
DOD-ARMY: Army Medical Research Acquisition Activity (USAMRAA)
9/1/21 → 8/31/24
Project: Research project